
|Videos|September 1, 2017
- Non-Small Cell Lung Cancer
- Volume 1
- Issue 1
Dr. Bazhenova on Potential Impact of Immunotherapy in Non-Driver NSCLC
Author(s)Lyudmila A. Bazhenova, MD
Lyudmila A. Bazhenova, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses what potential impact immunotherapy agents could have on outcomes for patients with non-driver non–small cell lung cancer.
Articles in this issue
about 8 years ago
Current Treatment Strategies in Nonbiomarker Nonsquamous NSCLCabout 8 years ago
Emerging Treatment Strategies in Nonsquamous NSCLCabout 8 years ago
Nonbiomarker NSCLC Population a Challenging Obstacle, Expert Says



































